prolinedithiocarbamate has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, HY; Xiao, XB; Zhao, XL | 1 |
| Assreuy, J; Freitas, MS; Santos-Silva, MC | 1 |
2 other study(ies) available for prolinedithiocarbamate and Leukemia
| Article | Year |
|---|---|
[Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro].
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Leukocytes, Mononuclear; Proline; Thiocarbamates; Tumor Cells, Cultured | 2005 |
Involvement of NF-kappaB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukemia cells.
Topics: Buthionine Sulfoximine; Carmustine; Cell Line, Tumor; Glutathione; Humans; Leukemia; NF-kappa B; Nitric Oxide; Paclitaxel; Proline; S-Nitroso-N-Acetylpenicillamine; Thiocarbamates | 2006 |